209 related articles for article (PubMed ID: 33052901)
1. A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling.
Semesta KM; Tian R; Kampmann M; von Zastrow M; Tsvetanova NG
PLoS Genet; 2020 Oct; 16(10):e1009103. PubMed ID: 33052901
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.
Toledo CM; Ding Y; Hoellerbauer P; Davis RJ; Basom R; Girard EJ; Lee E; Corrin P; Hart T; Bolouri H; Davison J; Zhang Q; Hardcastle J; Aronow BJ; Plaisier CL; Baliga NS; Moffat J; Lin Q; Li XN; Nam DH; Lee J; Pollard SM; Zhu J; Delrow JJ; Clurman BE; Olson JM; Paddison PJ
Cell Rep; 2015 Dec; 13(11):2425-2439. PubMed ID: 26673326
[TBL] [Abstract][Full Text] [Related]
3. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.
Kapolka NJ; Taghon GJ; Rowe JB; Morgan WM; Enten JF; Lambert NA; Isom DG
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13117-13126. PubMed ID: 32434907
[TBL] [Abstract][Full Text] [Related]
4. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
5. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
[TBL] [Abstract][Full Text] [Related]
6. Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.
Drozdov I; Svejda B; Gustafsson BI; Mane S; Pfragner R; Kidd M; Modlin IM
PLoS One; 2011; 6(8):e22457. PubMed ID: 21853033
[TBL] [Abstract][Full Text] [Related]
7. Members of the KCTD family are major regulators of cAMP signaling.
Muntean BS; Marwari S; Li X; Sloan DC; Young BD; Wohlschlegel JA; Martemyanov KA
Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34934014
[TBL] [Abstract][Full Text] [Related]
8. The psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction.
Semesta KM; Garces A; Tsvetanova NG
J Biol Chem; 2023 Sep; 299(9):105133. PubMed ID: 37543364
[TBL] [Abstract][Full Text] [Related]
9. Systematic Quantification of GPCR/cAMP-Controlled Protein Kinase A Interactions.
Torres-Quesada O; Röck R; Stefan E
Horm Metab Res; 2017 Apr; 49(4):240-249. PubMed ID: 28427097
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
11. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
Hayashi S; Morishita R; Matsushita H; Nakagami H; Taniyama Y; Nakamura T; Aoki M; Yamamoto K; Higaki J; Ogihara T
Hypertension; 2000 Jan; 35(1 Pt 2):237-43. PubMed ID: 10642304
[TBL] [Abstract][Full Text] [Related]
13. CANDLES, an assay for monitoring GPCR induced cAMP generation in cell cultures.
Trehan A; Rotgers E; Coffey ET; Huhtaniemi I; Rivero-Müller A
Cell Commun Signal; 2014 Nov; 12():70. PubMed ID: 25366423
[TBL] [Abstract][Full Text] [Related]
14. A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.
Vedel L; Bräuner-Osborne H; Mathiesen JM
J Biomol Screen; 2015 Aug; 20(7):849-57. PubMed ID: 25851033
[TBL] [Abstract][Full Text] [Related]
15. Imaging-based pooled CRISPR screening reveals regulators of lncRNA localization.
Wang C; Lu T; Emanuel G; Babcock HP; Zhuang X
Proc Natl Acad Sci U S A; 2019 May; 116(22):10842-10851. PubMed ID: 31085639
[TBL] [Abstract][Full Text] [Related]
16. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
Golla R; Seethala R
J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.
Broselid S; Berg KA; Chavera TA; Kahn R; Clarke WP; Olde B; Leeb-Lundberg LM
J Biol Chem; 2014 Aug; 289(32):22117-27. PubMed ID: 24962572
[TBL] [Abstract][Full Text] [Related]
18.
Li F; Huang Q; Luster TA; Hu H; Zhang H; Ng WL; Khodadadi-Jamayran A; Wang W; Chen T; Deng J; Ranieri M; Fang Z; Pyon V; Dowling CM; Bagdatlioglu E; Almonte C; Labbe K; Silver H; Rabin AR; Jani K; Tsirigos A; Papagiannakopoulos T; Hammerman PS; Velcheti V; Freeman GJ; Qi J; Miller G; Wong KK
Cancer Discov; 2020 Feb; 10(2):270-287. PubMed ID: 31744829
[TBL] [Abstract][Full Text] [Related]
19. CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators.
Fang L; Wang W; Li G; Zhang L; Li J; Gan D; Yang J; Tang Y; Ding Z; Zhang M; Zhang W; Deng D; Song Z; Zhu Q; Cui H; Hu Y; Chen W
Mol Syst Biol; 2020 Nov; 16(11):e10025. PubMed ID: 33251765
[TBL] [Abstract][Full Text] [Related]
20. p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons.
Klesse LJ; Parada LF
J Neurosci; 1998 Dec; 18(24):10420-8. PubMed ID: 9852579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
